The explanation can be sought in a greater expression of glucose transporter type 1 (GLUT-1) in squamous cell carcinomas than adenocarcinomas, as widely demonstrated in the literature [21,22,23,24]. The gene discussed is SLC2A1; the disease is adenocarcinoma.